venlafaxine
Selected indexed studies
- Venlafaxine-Associated Rhabdomyolysis: A Literature Review. (J Clin Psychopharmacol, 2024) [PMID:38506608]
- Venlafaxine pharmacogenetics: a comprehensive review. (Pharmacogenomics, 2019) [PMID:31368838]
- Venlafaxine-induced hypoglycemia. (CMAJ, 2021) [PMID:33875464]
_Worker-drafted node — pending editorial review._
Connections
venlafaxine is a side effect of
Sources
- Venlafaxine-induced hypoglycemia. (2021) pubmed
- Venlafaxine-Induced Urinary Retention. (2021) pubmed
- Venlafaxine-Associated Rhabdomyolysis: A Literature Review. (2024) pubmed
- Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. (2024) pubmed
- Venlafaxine pharmacogenetics: a comprehensive review. (2019) pubmed
- Venlafaxine and treatment-resistant depression. (2000) pubmed
- Venlafaxine-induced thrombocytopenia: A case report and literature review. (2025) pubmed
- Venlafaxine: more dangerous than most "selective" serotonergic antidepressants. (2016) pubmed
- Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder. (2024) pubmed
- Venlafaxine deprescribing and thyroid function. (2023) pubmed